Pharma H1 Exports up 5% to $16.14-Bn. as Europe Offsets U.S. Slowdown

Pharma H1 exports up 5% to $16.14-bn. as Europe offsets U.S. slowdown

Pharma exports rise 4.9% to $16.14B in H1 FY27 as Europe, Africa, LATAM, and ASEAN offset U.S. slowdown, boosting diverse growth.

India's pharma exports rise 4.9% to $16.14 bn in H1; shipments to Europe up nearly 10%: Pharmexcil

India's pharmaceutical exports grew nearly 5% to $16.13 billion in H1 FY27, driven by demand from Europe, ASEAN and Latin America, Pharmexcil data showed.

India’s pharma exports rise 4.90% to USD 16.14 billion in H1 FY27 as European demand surges

India’s pharmaceutical exports grew 4.90 per cent year-on-year to reach USD 16,135.93 million during the first half of the financial year 2026–27 (April–September 2026), up from USD 15,382.85 million recorded in H1 FY26.

India's pharma exports rise 4.90% to USD 16.14 billion in H1 FY27 as European demand surges

India's pharmaceutical exports grew 4.90 per cent year-on-year to reach USD 16,135.93 million during the first half of the financial year 2026-27 (April-September 2026), up from USD 15,382.85 million recorded in H1 FY26. According to the Pharmaceuticals Export Promotion Council of India (Pharmexcil), the expansion during the six-month period drew support from steady increases in shipments of drug formulations, biologicals, bulk drugs, drug inter…